- Home
- FENG vs DYAI Comparison
FENG vs DYAI Comparison
Compare FENG & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- DYAI
- Stock Information
- Founded
- FENG 1998
- DYAI 1979
- Country
- FENG China
- DYAI United States
- Employees
- FENG N/A
- DYAI N/A
- Industry
- FENG Broadcasting
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FENG Industrials
- DYAI Health Care
- Exchange
- FENG Nasdaq
- DYAI Nasdaq
- Market Cap
- FENG 26.8M
- DYAI 30.2M
- IPO Year
- FENG 2011
- DYAI 2004
- Fundamental
- Price
- FENG $2.66
- DYAI $1.00
- Analyst Decision
- FENG
- DYAI Strong Buy
- Analyst Count
- FENG 0
- DYAI 1
- Target Price
- FENG N/A
- DYAI $6.00
- AVG Volume (30 Days)
- FENG 19.2K
- DYAI 124.5K
- Earning Date
- FENG 11-11-2025
- DYAI 11-11-2025
- Dividend Yield
- FENG N/A
- DYAI N/A
- EPS Growth
- FENG N/A
- DYAI N/A
- EPS
- FENG N/A
- DYAI N/A
- Revenue
- FENG $101,168,374.00
- DYAI $4,135,078.00
- Revenue This Year
- FENG N/A
- DYAI $34.23
- Revenue Next Year
- FENG N/A
- DYAI $19.57
- P/E Ratio
- FENG N/A
- DYAI N/A
- Revenue Growth
- FENG 5.53
- DYAI 129.20
- 52 Week Low
- FENG $1.28
- DYAI $0.71
- 52 Week High
- FENG $3.49
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- FENG 59.09
- DYAI 58.46
- Support Level
- FENG $2.51
- DYAI $0.94
- Resistance Level
- FENG $2.68
- DYAI $1.01
- Average True Range (ATR)
- FENG 0.22
- DYAI 0.05
- MACD
- FENG 0.01
- DYAI 0.01
- Stochastic Oscillator
- FENG 55.17
- DYAI 58.82
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.